Illumina, Inc.
Non-invasive prenatal diagnosis of fetal genetic condition using cellular DNA and cell free DNA

Last updated:

Abstract:

Disclosed are methods for determining at least one sequence of interest of a fetus of a pregnant mother. In various embodiments, the method can determine one or more sequences of interest in a test sample that comprises a mixture of maternal cellular DNA and mother-and-fetus cfDNA. In some embodiments, methods are provided for determining whether the fetus has a genetic disease. In some embodiments, methods are provided for determining whether the fetus is homozygous in a disease causing allele when the mother is heterozygous of the same allele. In some embodiments, methods are provided for determining whether the fetus has a copy number variation (CNV) or a non-CNV genetic sequence anomaly.

Status:
Grant
Type:

Utility

Filling date:

9 Aug 2018

Issue date:

17 Nov 2020